STRAW VII Workshop
This meeting regularly attracts researchers and clinicians interested in stroke across the Commonwealth and throughout the USA. STRAW VII: New Advances in Stroke Research. will focus on a translational approach to stroke and related cerebrovascular diseases. Topics will include new insights into novel approaches to pharmacotherapies for cerebrovascular diseases, as presented and discussed by clinical and basic scientists. This year’s speakers include Drs Walter Lowe (Neuroprotection strategies for ischemic and hemorrhagic stroke), Paul Sanberg (Intellectual Property for Translational Sciences), Lisa Wruck (Post-Stroke Cognitive Impairment) and Patrick Fillingham (Predicting cerebral vasospasm after subarachnoid hemorrhage).
As per tradition, the meeting will have no registration fee and will also include an optional excursion in the ‘land of horses and bourbon’, facilitating opportunities for networking with like-minded research scientists.
Speakers
Patrick Fillingham, PhD
University of Washington Department of Neurological Surgery
"Computational simulation as a clinical tool for evaluating cerebral aneurysms"
About Dr. Fillingham
Dr. Patrick Fillingham is an Assistant Professor at the Stoke and Applied Neuroscience Center in the Neurological Surgery Department at the University of Washington. He completed is PhD in Mechanical Engineering at the University of Washington in 2020 before joining the Neurological Surgery department in July of 2020. Dr. Fillingham's research employs patient-specific computational simulations to investigate the mechanical factors that contribute to neurological disorders such as hydrocephalus, Alzheimer's Disease, cerebral aneurysms, and stroke. His current focus is on developing a clinically applicable computational frameworks for evaluating hemodynamically optimal treatment strategies for cerebral aneurysms and for predicting cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
About Dr. Fillingham
Dr. Patrick Fillingham is an Assistant Professor at the Stoke and Applied Neuroscience Center in the Neurological Surgery Department at the University of Washington. He completed is PhD in Mechanical Engineering at the University of Washington in 2020 before joining the Neurological Surgery department in July of 2020. Dr. Fillingham's research employs patient-specific computational simulations to investigate the mechanical factors that contribute to neurological disorders such as hydrocephalus, Alzheimer's Disease, cerebral aneurysms, and stroke. His current focus is on developing a clinically applicable computational frameworks for evaluating hemodynamically optimal treatment strategies for cerebral aneurysms and for predicting cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Paul R. Sanberg, PhD, MD, DSc
University of South Florida Department of Neurosurgery
Unlocking Innovation: Intellectual Property Consideration for Translational Success
About Dr. Sanberg
Paul R. Sanberg, PhD, MD, DSc, is the President and Founder of the National Academy of Inventors. Sanberg helped lead the team that demonstrated the use of umbilical cord blood derived cells for neurological disease. His research has advanced understanding and design of pharmaceutical and cellular therapeutics for stroke, Alzheimer's, ALS, Huntington's, Parkinson's disease and Tourette syndrome. Inventor on 167 U.S. and foreign patents, author of over 700 articles and 14 books, with more than 43,000 citations, Sanberg has served on editorial boards of 30 scientific journals and many scientific advisory boards, including NIDA and Johnson & Johnson. He has extensive industry experience as a founder/co-founder of companies involved in cell therapy for degenerative disorders. Additionally, he has received awards and fellowships from numerous societies and academies and served on the National Medal of Innovation and Technology Committee of the US Patent and Trademark office.
About Dr. Sanberg
Paul R. Sanberg, PhD, MD, DSc, is the President and Founder of the National Academy of Inventors. Sanberg helped lead the team that demonstrated the use of umbilical cord blood derived cells for neurological disease. His research has advanced understanding and design of pharmaceutical and cellular therapeutics for stroke, Alzheimer's, ALS, Huntington's, Parkinson's disease and Tourette syndrome. Inventor on 167 U.S. and foreign patents, author of over 700 articles and 14 books, with more than 43,000 citations, Sanberg has served on editorial boards of 30 scientific journals and many scientific advisory boards, including NIDA and Johnson & Johnson. He has extensive industry experience as a founder/co-founder of companies involved in cell therapy for degenerative disorders. Additionally, he has received awards and fellowships from numerous societies and academies and served on the National Medal of Innovation and Technology Committee of the US Patent and Trademark office.
Walter C. Low, PhD
University of Minnesota Department of Neurosurgery
"Stem Cell-Based Therapies for Treating Ischemic Brain Injury"
About Dr. Low
Dr. Low is a Professor in the Department of Neurosurgery and the Stem Cell Institute at the University of Minnesota. He received his Ph.D. in Bioengineering at the University of Michigan, and was a Postdoctoral Fellow at University of Cambridge in the United Kingdom. He also served as a Past President of the American Society for Neural Therapy and Repair. His work has focused on developing cell and gene therapy-based therapies for treating a variety of neurological disorders. His current projects include the generation of products derived from human brain organoids for repairing the injured brain.
About Dr. Low
Dr. Low is a Professor in the Department of Neurosurgery and the Stem Cell Institute at the University of Minnesota. He received his Ph.D. in Bioengineering at the University of Michigan, and was a Postdoctoral Fellow at University of Cambridge in the United Kingdom. He also served as a Past President of the American Society for Neural Therapy and Repair. His work has focused on developing cell and gene therapy-based therapies for treating a variety of neurological disorders. His current projects include the generation of products derived from human brain organoids for repairing the injured brain.
Marcelo Rocha, PhD
University of Pittsburgh
Department of Neurology
About Dr. Rocha
Dr. Rocha’s clinical and research interests focus on the management, diagnosis and prevention of acute stroke. The goal of his research is to identify the pathophysiological mechanisms of individual tolerance to different stroke sub-types and aging. These findings will be used to identify targets for novel therapies to improve patient outcomes after stroke.
About Dr. Rocha
Dr. Rocha’s clinical and research interests focus on the management, diagnosis and prevention of acute stroke. The goal of his research is to identify the pathophysiological mechanisms of individual tolerance to different stroke sub-types and aging. These findings will be used to identify targets for novel therapies to improve patient outcomes after stroke.